Patents by Inventor Yumi Yokoyama

Yumi Yokoyama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATIONS FOR THE TREATMENT OF CANCER
    Publication number: 20190224200
    Abstract: The present disclosure relates to certain combinations for the treatment of cancer in a subject, comprising one or more inhibitors of Tyro3, Axl, Mer, or c-Met, together with one or more compounds that are inhibitors of programmed cell death protein 1 (PD-1) or programmed death-ligand 1 (PD-L1).
    Type: Application
    Filed: August 22, 2017
    Publication date: July 25, 2019
    Applicant: IGNYTA, INC.
    Inventors: Eric Santos MARTIN, Yumi YOKOYAMA
  • COMBINATIONS FOR THE TREATMENT OF CANCER
    Publication number: 20190185567
    Abstract: The present disclosure relates to certain combinations for the treatment of cancer in a subject, comprising one or more inhibitors of Tyro3, Axl, Mer, or c-Met, together with one or more compounds that are inhibitors of cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4).
    Type: Application
    Filed: July 28, 2017
    Publication date: June 20, 2019
    Applicant: IGNYTA, INC.
    Inventors: Eric Santos MARTIN, Yumi YOKOYAMA
  • Genetic modification of endostatin
    Patent number: 6825167
    Abstract: Chimeric polypeptides comprising a targeting moiety and an antiangiogeneic polypeptide are provided, as well as methods of using the chimeric polypeptides.
    Type: Grant
    Filed: April 4, 2001
    Date of Patent: November 30, 2004
    Assignee: Regents of the University of Minnesota
    Inventors: Yumi Yokoyama, S. Ramakrishnan
  • HPLC apparatus for fractioning and preparing sample for NMR spectrometry and method of changing mobile phase
    Patent number: 6498040
    Abstract: A high-performance liquid chromatography apparatus and a process for conversion of mobile phase, enabling a trace amount of sample for NMR analysis to be efficiently separated and prepared, includes steps of separating a target ingredient from the sample by the high-performance liquid chromatography, trapping the target ingredient in a trapping column using a different mobile phase, replacing water by deuterium oxide and eluting this target ingredient from the trapping column using deuterated solvent other than deuterium oxide.
    Type: Grant
    Filed: February 10, 2000
    Date of Patent: December 24, 2002
    Assignee: Eisai Co., Ltd.
    Inventors: Yumi Yokoyama, Naoya Kishi, Masayuki Tanaka, Naoki Asakawa